{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:53:55Z","timestamp":1770350035741,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Motivation<\/jats:title>\n                <jats:p>Drug combination therapies have shown promise in clinical cancer treatments. However, it is hard to experimentally identify all drug combinations for synergistic interaction even with high-throughput screening due to the vast space of potential combinations. Although a number of computational methods for drug synergy prediction have proven successful in narrowing down this space, fusing drug pairs and cell line features effectively still lacks study, hindering current algorithms from understanding the complex interaction between drugs and cell lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this paper, we proposed a Permutable feature fusion network for Drug-Drug Synergy prediction, named PermuteDDS. PermuteDDS takes multiple representations of drugs and cell lines as input and employs a permutable fusion mechanism to combine drug and cell line features. In experiments, PermuteDDS exhibits state-of-the-art performance on two benchmark data sets. Additionally, the results on independent test set grouped by different tissues reveal that PermuteDDS has good generalization performance. We believed that PermuteDDS is an effective and valuable tool for identifying synergistic drug combinations. It is publicly available at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/littlewei-lazy\/PermuteDDS\">https:\/\/github.com\/littlewei-lazy\/PermuteDDS<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Scientific contribution<\/jats:title>\n                <jats:p>First, this paper proposes a permutable feature fusion network for predicting drug synergy termed PermuteDDS, which extract diverse information from multiple drug representations and cell line representations. Second, the permutable fusion mechanism combine the drug and cell line features by integrating information of different channels, enabling the utilization of complex relationships between drugs and cell lines. Third, comparative and ablation experiments provide evidence of the efficacy of PermuteDDS in predicting drug-drug synergy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13321-024-00839-8","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:02:09Z","timestamp":1713175329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["PermuteDDS: a permutable feature fusion network for drug-drug synergy prediction"],"prefix":"10.1186","volume":"16","author":[{"given":"Xinwei","family":"Zhao","sequence":"first","affiliation":[]},{"given":"Junqing","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Youyuan","family":"Shui","sequence":"additional","affiliation":[]},{"given":"Mengdie","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Che","sequence":"additional","affiliation":[]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"1","key":"839_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","volume":"14","author":"JS Lopez","year":"2017","unstructured":"Lopez JS, Banerji U (2017) Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nat Rev Clin Oncol 14(1):57\u201366","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"839_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nbt.2284","volume":"30","author":"B Al-Lazikani","year":"2012","unstructured":"Al-Lazikani B, Banerji U, Workman P (2012) Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol 30(7):679\u2013692","journal-title":"Nat Biotechnol"},{"issue":"6474","key":"839_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.aay3041","volume":"367","author":"J Liu","year":"2020","unstructured":"Liu J, Gefen O, Ronin I, Bar-Meir M, Balaban NQ (2020) Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science 367(6474):200\u2013204","journal-title":"Science"},{"key":"839_CR4","doi-asserted-by":"crossref","unstructured":"Azam F, Vazquez A (2021) Trends in Phase II Trials for Cancer Therapies. Cancers 2021, 13, 178. s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in\u00a0..","DOI":"10.3390\/cancers13020178"},{"issue":"12","key":"839_CR5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/bioinformatics\/btv080","volume":"31","author":"P Li","year":"2015","unstructured":"Li P, Huang C, Fu Y, Wang J, Wu Z, Ru J, Zheng C, Guo Z, Chen X, Zhou W et al (2015) Large-scale exploration and analysis of drug combinations. Bioinformatics 31(12):2007\u20132016","journal-title":"Bioinformatics"},{"issue":"11","key":"839_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nrd941","volume":"1","author":"J Bajorath","year":"2002","unstructured":"Bajorath J (2002) Integration of virtual and high-throughput screening. Nat Rev Drug Discov 1(11):882\u2013894","journal-title":"Nat Rev Drug Discov"},{"key":"839_CR7","first-page":"139","volume":"1","author":"D Ferreira","year":"2013","unstructured":"Ferreira D, Adega F, Chaves R (2013) The importance of cancer cell lines as in vitro models in cancer methylome analysis and anticancer drugs testing. Oncogenomics 1:139\u2013166","journal-title":"Oncogenomics"},{"issue":"10","key":"839_CR8","first-page":"544","volume":"5","author":"MK Morris","year":"2016","unstructured":"Morris MK, Clarke DC, Osimiri LC, Lauffenburger DA (2016) Systematic analysis of quantitative logic model ensembles predicts drug combination effects on cell signaling networks. CPT 5(10):544\u2013553","journal-title":"CPT"},{"issue":"9","key":"839_CR9","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2018","unstructured":"Preuer K, Lewis RP, Hochreiter S, Bender A, Bulusu KC, Klambauer G (2018) Deepsynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics 34(9):1538\u20131546","journal-title":"Bioinformatics"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45:5\u201332","journal-title":"Mach Learn"},{"issue":"12","key":"839_CR11","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble WS (2006) What is a support vector machine? Nat Biotechnol 24(12):1565\u20131567","journal-title":"Nat Biotechnol"},{"key":"839_CR12","unstructured":"Chen T, He T, Benesty M, Khotilovich V, Tang Y, Cho H, Chen K, Mitchell R, Cano I, Zhou T et al (2015) Xgboost: extreme gradient boosting. R package version 0.4-2 1(4):1\u20134"},{"issue":"3","key":"839_CR13","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s11831-021-09617-3","volume":"29","author":"V Kumar","year":"2022","unstructured":"Kumar V, Dogra N (2022) A comprehensive review on deep synergistic drug prediction techniques for cancer. Arch Comput Methods Eng 29(3):1443\u20131461","journal-title":"Arch Comput Methods Eng"},{"issue":"2","key":"839_CR14","first-page":"59","volume":"12","author":"M Jeon","year":"2018","unstructured":"Jeon M, Kim S, Park S, Lee H, Kang J (2018) In silico drug combination discovery for personalized cancer therapy. BMC Syst Biol 12(2):59\u201367","journal-title":"BMC Syst Biol"},{"issue":"9","key":"839_CR15","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","volume":"78","author":"L He","year":"2018","unstructured":"He L, Tang J, Andersson EI, Timonen S, Koschmieder S, Wennerberg K, Mustjoki S, Aittokallio T (2018) Patient-customized drug combination prediction and testing for t-cell prolymphocytic leukemia patients. Can Res 78(9):2407\u20132418","journal-title":"Can Res"},{"issue":"4","key":"839_CR16","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1109\/TCBB.2021.3086702","volume":"19","author":"HI Kuru","year":"2021","unstructured":"Kuru HI, Tastan O, Cicek AE (2021) Matchmaker: a deep learning framework for drug synergy prediction. IEEE\/ACM Trans Comput Biol Bioinf 19(4):2334\u20132344","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"issue":"8","key":"839_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/bioinformatics\/btt105","volume":"29","author":"D-S Cao","year":"2013","unstructured":"Cao D-S, Xu Q-S, Hu Q-N, Liang Y-Z (2013) Chemopy: freely available python package for computational biology and chemoinformatics. Bioinformatics 29(8):1092\u20131094","journal-title":"Bioinformatics"},{"issue":"2","key":"839_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/bib\/bbab562","volume":"23","author":"W Lin","year":"2022","unstructured":"Lin W, Wu L, Zhang Y, Wen Y, Yan B, Dai C, Liu K, He S, Bo X (2022) An enhanced cascade-based deep forest model for drug combination prediction. Brief Bioinform 23(2):562","journal-title":"Brief Bioinform"},{"issue":"1","key":"839_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/bib\/bbac588","volume":"24","author":"S-R Hosseini","year":"2023","unstructured":"Hosseini S-R, Zhou X (2023) Ccsynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy. Brief Bioinform 24(1):588","journal-title":"Brief Bioinform"},{"issue":"1","key":"839_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger D (1988) Smiles, a chemical language and information system. 1. introduction to methodology and encoding rules. J Chem Inf Comput Sci 28(1):31\u201336","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"839_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jamia\/ocaa212","volume":"28","author":"Y Kim","year":"2021","unstructured":"Kim Y, Zheng S, Tang J, Jim Zheng W, Li Z, Jiang X (2021) Anticancer drug synergy prediction in understudied tissues using transfer learning. J Am Med Inform Assoc 28(1):42\u201351","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"839_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/bfgp\/elab036","volume":"20","author":"L Yu","year":"2021","unstructured":"Yu L, Su Y, Liu Y, Zeng X (2021) Review of unsupervised pretraining strategies for molecules representation. Brief Funct Genomics 20(5):323\u2013332","journal-title":"Brief Funct Genomics"},{"issue":"1","key":"839_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/bib\/bbab390","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Shen S, Deng L, Liu H (2022) Deepdds: deep graph neural network with attention mechanism to predict synergistic drug combinations. Brief Bioinform 23(1):390","journal-title":"Brief Bioinform"},{"issue":"20","key":"839_CR24","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1093\/bioinformatics\/btac579","volume":"38","author":"X Liu","year":"2022","unstructured":"Liu X, Song C, Liu S, Li M, Zhou X, Zhang W (2022) Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction. Bioinformatics 38(20):4782\u20134789","journal-title":"Bioinformatics"},{"issue":"6","key":"839_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O\u2019Neil","year":"2016","unstructured":"O\u2019Neil J, Benita Y, Feldman I, Chenard M, Roberts B, Liu Y, Li J, Kral A, Lejnine S, Loboda A et al (2016) An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther 15(6):1155\u20131162. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0843","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"839_CR26","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","volume":"77","author":"SL Holbeck","year":"2017","unstructured":"Holbeck SL, Camalier R, Crowell JA, Govindharajulu JP, Hollingshead M, Anderson LW, Polley E, Rubinstein L, Srivastava A, Wilsker D et al (2017) The national cancer institute almanac: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity. Can Res 77(13):3564\u20133576","journal-title":"Can Res"},{"issue":"6","key":"839_CR27","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3(6):285\u2013290","journal-title":"Arzneimittelforschung"},{"key":"839_CR28","doi-asserted-by":"publisher","unstructured":"Bliss CI, The toxicity of poisons applied jointly. Ann Appl Biol 26(3):585\u2013615. https:\/\/doi.org\/10.1111\/j.1744-7348.1939.tb06990.x","DOI":"10.1111\/j.1744-7348.1939.tb06990.x"},{"issue":"D1","key":"839_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B et al (2019) Pubchem 2019 update: improved access to chemical data. Nucleic Acids Res 47(D1):1102\u20131109","journal-title":"Nucleic Acids Res"},{"key":"839_CR30","first-page":"31","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum G et al (2013) Rdkit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8:31","journal-title":"Greg Landrum"},{"issue":"3","key":"839_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gon\u00e7alves E, Barthorpe S, Lightfoot H et al (2016) A landscape of pharmacogenomic interactions in cancer. Cell 166(3):740\u2013754","journal-title":"Cell"},{"issue":"D1","key":"839_CR32","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR et al (2012) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41(D1):955\u2013961","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"839_CR33","first-page":"588","volume":"5","author":"L Cheng","year":"2016","unstructured":"Cheng L, Li L (2016) Systematic quality control analysis of lincs data. CPT 5(11):588\u2013598","journal-title":"CPT"},{"issue":"2","key":"839_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1021\/ci00054a008","volume":"27","author":"R Nilakantan","year":"1987","unstructured":"Nilakantan R, Bauman N, Dixon JS, Venkataraghavan R (1987) Topological torsion: a new molecular descriptor for SAR applications. Comparison with other descriptors. J Chem Inf Comput Sci 27(2):82\u201385","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"839_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-00445-4","volume":"12","author":"A Capecchi","year":"2020","unstructured":"Capecchi A, Probst D, Reymond J-L (2020) One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome. J Cheminf 12(1):1\u201315","journal-title":"J Cheminf"},{"issue":"6","key":"839_CR36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/ci010132r","volume":"42","author":"JL Durant","year":"2002","unstructured":"Durant JL, Leland BA, Henry DR, Nourse JG (2002) Reoptimization of mdl keys for use in drug discovery. J Chem Inf Comput Sci 42(6):1273\u20131280","journal-title":"J Chem Inf Comput Sci"},{"key":"839_CR37","unstructured":"Hendrycks D, Gimpel K (2016) Gaussian error linear units (gelus). arXiv preprint arXiv:1606.08415"},{"key":"839_CR38","first-page":"24261","volume":"34","author":"IO Tolstikhin","year":"2021","unstructured":"Tolstikhin IO, Houlsby N, Kolesnikov A, Beyer L, Zhai X, Unterthiner T, Yung J, Steiner A, Keysers D, Uszkoreit J et al (2021) Mlp-mixer: an all-mlp architecture for vision. Adv Neural Inf Process Syst 34:24261\u201324272","journal-title":"Adv Neural Inf Process Syst"},{"issue":"1","key":"839_CR39","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1109\/TPAMI.2022.3145427","volume":"45","author":"Q Hou","year":"2022","unstructured":"Hou Q, Jiang Z, Yuan L, Cheng M-M, Yan S, Feng J (2022) Vision permutator: a permutable MLP-like architecture for visual recognition. IEEE Trans Pattern Anal Mach Intell 45(1):1328\u20131334","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"839_CR40","unstructured":"Ramachandran P, Zoph B, Le QV (2017) Searching for activation functions. arXiv preprint arXiv:1710.05941"},{"key":"839_CR41","unstructured":"Ba JL, Kiros JR, Hinton GE (2016) Layer normalization. arXiv preprint arXiv:1607.06450"},{"issue":"16","key":"839_CR42","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1093\/bioinformatics\/btaa287","volume":"36","author":"Z Sun","year":"2020","unstructured":"Sun Z, Huang S, Jiang P, Hu P (2020) Dtf: deep tensor factorization for predicting anticancer drug synergy. Bioinformatics 36(16):4483\u20134489","journal-title":"Bioinformatics"},{"issue":"1","key":"839_CR43","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41467-020-19950-z","volume":"11","author":"H Julkunen","year":"2020","unstructured":"Julkunen H, Cichonska A, Gautam P, Szedmak S, Douat J, Pahikkala T, Aittokallio T, Rousu J (2020) Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects. Nat Commun 11(1):6136","journal-title":"Nat Commun"},{"key":"839_CR44","doi-asserted-by":"crossref","unstructured":"Celebi R, Bear Don\u2019t\u00a0Walk O, Movva R, Alpsoy S, Dumontier M (2019) In-silico prediction of synergistic anti-cancer drug combinations using multi-omics data. Sci Rep 9(1), 1\u201310","DOI":"10.1038\/s41598-019-45236-6"},{"issue":"2","key":"839_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cels.2020.11.013","volume":"12","author":"B Yuan","year":"2021","unstructured":"Yuan B, Shen C, Luna A, Korkut A, Marks DS, Ingraham J, Sander C (2021) Cellbox: interpretable machine learning for perturbation biology with application to the design of cancer combination therapy. Cell Syst 12(2):128\u2013140","journal-title":"Cell Syst"},{"issue":"D1","key":"839_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S et al (2015) Cosmic: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res 43(D1):805\u2013811","journal-title":"Nucleic Acids Res"},{"key":"839_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-017-0319-2","volume":"10","author":"B Thibault","year":"2017","unstructured":"Thibault B, Jean-Claude B (2017) Dasatinib+ gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells. Journal of ovarian research 10:1\u201312","journal-title":"Journal of ovarian research"},{"issue":"1\u20132","key":"839_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2014.04.009","volume":"350","author":"SC Dolfi","year":"2014","unstructured":"Dolfi SC, J\u00e4ger AV, Medina DJ, Haffty BG, Yang J-M, Hirshfield KM (2014) Fulvestrant treatment alters mdm2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett 350(1\u20132):52\u201360","journal-title":"Cancer Lett"},{"key":"839_CR49","unstructured":"Shen Z, Liu J, He Y, Zhang X, Xu R, Yu H, Cui P (2021) Towards out-of-distribution generalization: a survey. arXiv preprint arXiv:2108.13624"},{"key":"839_CR50","first-page":"12964","volume":"35","author":"N Yang","year":"2022","unstructured":"Yang N, Zeng K, Wu Q, Jia X, Yan J (2022) Learning substructure invariance for out-of-distribution molecular representations. Adv Neural Inf Process Syst 35:12964\u201312978","journal-title":"Adv Neural Inf Process Syst"},{"issue":"1","key":"839_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-016-0148-0","volume":"8","author":"NM O\u2019Boyle","year":"2016","unstructured":"O\u2019Boyle NM, Sayle RA (2016) Comparing structural fingerprints using a literature-based similarity benchmark. J Cheminf 8(1):1\u201314","journal-title":"J Cheminf"},{"issue":"6","key":"839_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/bioinformatics\/btad351","volume":"39","author":"X Wang","year":"2023","unstructured":"Wang X, Zhu H, Chen D, Yu Y, Liu Q, Liu Q (2023) A complete graph-based approach with multi-task learning for predicting synergistic drug combinations. Bioinformatics 39(6):351","journal-title":"Bioinformatics"},{"issue":"3","key":"839_CR53","doi-asserted-by":"publisher","first-page":"1010951","DOI":"10.1371\/journal.pcbi.1010951","volume":"19","author":"P Zhang","year":"2023","unstructured":"Zhang P, Tu S (2023) MGAE-DC: Predicting the synergistic effects of drug combinations through multi-channel graph autoencoders. PLoS Comput Biol 19(3):1010951","journal-title":"PLoS Comput Biol"},{"key":"839_CR54","doi-asserted-by":"publisher","first-page":"087","DOI":"10.1093\/gigascience\/giac087","volume":"11","author":"AJ Preto","year":"2022","unstructured":"Preto AJ, Matos-Filipe P, Mour\u00e3o J, Moreira IS (2022) Synpred: prediction of drug combination effects in cancer using different synergy metrics and ensemble learning. GigaScience 11:087","journal-title":"GigaScience"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-024-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-024-00839-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-024-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:10:39Z","timestamp":1713179439000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-024-00839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s13321-024-00839-8","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no Conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}